Bergan RC - Search Results

1

Androgen receptor-independent function of FoxA1 in prostate cancer metastasis.

Jin HJ, Zhao JC, Ogden I, Bergan RC, Yu J. Jin HJ, et al. Among authors: bergan rc. Cancer Res. 2013 Jun 15;73(12):3725-36. doi: 10.1158/0008-5472.CAN-12-3468. Epub 2013 Mar 28. Cancer Res. 2013. PMID: 23539448 Free PMC article.

2

Chemoprevention in prostate cancer.

Nabhan C, Bergan R. Nabhan C, et al. Cancer Treat Res. 2001;106:103-36. doi: 10.1007/978-1-4615-1657-6_5. Cancer Treat Res. 2001. PMID: 11225000 Review. No abstract available.

3

Some aspects of analysis of gene array data.

Jovanovic BD, Bergan RC, Kibbe WA. Jovanovic BD, et al. Among authors: bergan rc. Cancer Treat Res. 2002;113:71-89. doi: 10.1007/978-1-4757-3571-0_5. Cancer Treat Res. 2002. PMID: 12613351 Review. No abstract available.

4

An analysis of gene array data related to cell adhesion and prostate cancer.

Jovanovic BD, Huang S, Liu Y, Naguib KN, Bergan RC. Jovanovic BD, et al. Among authors: bergan rc. Cancer Treat Res. 2002;113:91-111. doi: 10.1007/978-1-4757-3571-0_6. Cancer Treat Res. 2002. PMID: 12613352 Review. No abstract available.

5

Gene expression profiling of renal medullary carcinoma: potential clinical relevance.

Yang XJ, Sugimura J, Tretiakova MS, Furge K, Zagaja G, Sokoloff M, Pins M, Bergan R, Grignon DJ, Stadler WM, Vogelzang NJ, Teh BT. Yang XJ, et al. Cancer. 2004 Mar 1;100(5):976-85. doi: 10.1002/cncr.20049. Cancer. 2004. PMID: 14983493 Free article.

6

Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells.

Huang X, Chen S, Xu L, Liu Y, Deb DK, Platanias LC, Bergan RC. Huang X, et al. Among authors: bergan rc. Cancer Res. 2005 Apr 15;65(8):3470-8. doi: 10.1158/0008-5472.CAN-04-2807. Cancer Res. 2005. PMID: 15833883

7

Phase II study of mitoxantrone and ketoconazole for hormone-refractory prostate cancer.

Eklund J, Kozloff M, Vlamakis J, Starr A, Mariott M, Gallot L, Jovanovic B, Schilder L, Robin E, Pins M, Bergan RC. Eklund J, et al. Among authors: bergan rc. Cancer. 2006 Jun 1;106(11):2459-65. doi: 10.1002/cncr.21880. Cancer. 2006. PMID: 16615097 Free article. Clinical Trial.

8

Characterization of a method for profiling gene expression in cells recovered from intact human prostate tissue using RNA linear amplification.

Ding Y, Xu L, Chen S, Jovanovic BD, Helenowski IB, Kelly DL, Catalona WJ, Yang XJ, Pins M, Ananthanarayanan V, Bergan RC. Ding Y, et al. Among authors: bergan rc. Prostate Cancer Prostatic Dis. 2006;9(4):379-91. doi: 10.1038/sj.pcan.4500888. Epub 2006 Jun 20. Prostate Cancer Prostatic Dis. 2006. PMID: 16786039

9

Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway.

Craft CS, Romero D, Vary CP, Bergan RC. Craft CS, et al. Among authors: bergan rc. Oncogene. 2007 Nov 8;26(51):7240-50. doi: 10.1038/sj.onc.1210533. Epub 2007 May 14. Oncogene. 2007. PMID: 17496924 Free PMC article.

10

Genistein induces phenotypic reversion of endoglin deficiency in human prostate cancer cells.

Craft CS, Xu L, Romero D, Vary CP, Bergan RC. Craft CS, et al. Among authors: bergan rc. Mol Pharmacol. 2008 Jan;73(1):235-42. doi: 10.1124/mol.107.038935. Epub 2007 Oct 19. Mol Pharmacol. 2008. PMID: 17951357

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters